SIC 8731
Services-Commercial Physical & Biological Research
15 companies · 3 with disclosed financials
Total revenue (latest)
$14.22B
Total net income
—
Avg net margin
—
Median net margin
—
5-year industry trend
Total revenue summed across 15 companies in the most recent fiscal year. Median margin is the cross-sectional median per year.
Largest by revenue
- 1IQVIQVIA HOLDINGS INC.
$32.09B cap · as of 2025-09-30
$11.95B
revenue
- 2INCYINCYTE CORP
$19.41B cap · as of 2026-03-31
$1.27B
revenue
- 3CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.
$7.34B cap · as of 2025-09-27
$1.00B
revenue
- 4MEDPMedpace Holdings, Inc.
$12.36B cap
—
revenue
- 5OABIOmniAb, Inc.
$384.2M cap
—
revenue
- 6MXCTMAXCYTE, INC.
$111.9M cap
—
revenue
- 7BIAFbioAffinity Technologies, Inc.
—
revenue
- 8NOTVInotiv, Inc.
—
revenue
- 9BUDZWEED, INC.
$4.4M cap
—
revenue
- 10ISPCiSpecimen Inc.
—
revenue
- 11CBIHCannabis Bioscience International Holdings, Inc.
$3.5M cap
—
revenue
- 12ONMDOneMedNet Corp
—
revenue
- 13NRCNRC HEALTH
$430.0M cap
—
revenue
- 14ABSIAbsci Corp
$795.1M cap
—
revenue
- 15FOXOFOXO TECHNOLOGIES INC.
—
revenue
Insider activity in this industry · last 12 months
Insider buying
$5.7M
Insider selling
$392.9M
Net flow
−$387.2M
Distinct insiders
51
Open-market trades summed across all 6 companies in the industry where insiders bought. Sales counted across all companies regardless. Filed via SEC Form 4.
Recently filed in this industry
Related industries
About the Services-Commercial Physical & Biological Research industry on ActaClear
ActaClear tracks 15 US-listed public companies classified under SEC SIC code 8731 (Services-Commercial Physical & Biological Research). Combined latest-period revenue across the sector is $14.22B,
Every name on this page links to a full company dashboard with 5-year SEC financials, live market data, ratios, AI-summarised business description, insider transactions, and institutional ownership. Data is sourced directly from SEC EDGAR XBRL filings and refreshed continuously.